Search
for
Sort by
Research 301–330 of 1000+
- Melatonin Receptors and Their Role in Human Diseases
- Androgen replacement therapy in women
- GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
- A Novel Nomogram for Predicting Gonadotropin-Releasing Hormone Analogue Treatment Outcome in Girls with Idiopathic Central Precocious Puberty
- Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- Australasian Society for Dermatology Research Meeting, May 2006
- Patients, Power and Responsibility
- Introduction to Transplantology
- News and Announcements
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Nonsurgical Therapy for Hair Loss
- Polycystic ovarian syndrome
- Transforming growth factor-β in stem cells and tissue homeostasis
- ACNE
- Familial Sexual Precocity
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Arzneimitteltherapie der Alopezien
- Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice
- Resfriamento de couro cabeludo para prevenção de alopecia induzida por quimioterapia: Estudo descritivo
- Long and short non-coding RNA and radiation response: a review
- COVID-19 in Africa: an ovarian victory?
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis
- Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023
- Whole brain radiotherapy with partial hair-sparing technique-a feasibility study
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis
- Polycystic ovary syndrome in North America
- Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia